11th Sep 2009 15:15
For Immediate Release 11 September 2009
MedicX Fund Limited
Issue of new ordinary shares
MedicX Fund Limited (the "Company") announces that earlier today it issued for cash 750,000 new ordinary shares of no par value in the Company (the "New Shares"). The issue price per New Share (before expenses) is 70.25 pence.
The net proceeds will be used in further pursuing the investment objectives of the Company.
The New Shares will be admitted to the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange's main market for listed securities pursuant to the block listing application announced by the Company on 26 June 2008.
Following this issue, the Company has 104,521,215 ordinary shares in issue.
For further information, please contact:
MedicX Fund Limited
David Staples, Chairman +44 (0)1481 723 450
MedicX Group
Keith Maddin, Chairman
Mike Adams, Managing Director +44 (0)808 2025461
Buchanan Communications
Charles Ryland/Miranda Higham/Mary-Jane Johnson +44(0)20 7466 5000
Collins Stewart Europe Limited
Andrew Zychowski/Robbie Robertson +44 (0)20 7523 8000
Collins Stewart Europe Limited, which is authorised and regulated by the Financial Services Authority, is acting for MedicX Fund Limited and for no one else in connection with the matters detailed in this announcement and will not be responsible to anyone other than MedicX Fund Limited for providing the protections afforded to clients of Collins Stewart Europe Limited or for affording advice in relation hereto, or any other matters referred to herein.
Related Shares:
Medicx Fund